We use cookies to improve your experience. See our Privacy Policy.
Argenx Se is a biological products, (no diagnostic substances) company incorporated in P7, trading on the Nasdaq.
Exchange
Nasdaq
Sector
Healthcare
Filer Category
Large accelerated filer
Fiscal Year End
December
Argenx Se is a biological products, (no diagnostic substances) company incorporated in P7, trading on the Nasdaq.
No SEC filings have been processed for ARGX yet. Filings will be analyzed automatically when the EDGAR pipeline next runs.
No recent insider transactions have been detected in ARGX SEC filings.
Argenx Se is incorporated in P7 and is classified as a Large accelerated filer filer with the SEC.
Argenx Se's fiscal year ends in December. Annual 10-K reports are typically filed within 60-90 days after the fiscal year end.
Data sourced from SEC EDGAR public filings. For informational purposes only — not investment advice. AI-generated summaries may contain errors. See our full disclaimer.